Prevalence of Imipenem-Resistant Acinetobacter baumannii isolates in Iran: A Meta-Analysis

Reference List
1. Johnson JK, Robinson GL, Zhao L, Harris AD, Stine OC, Thom KA. Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis. 2016;86(4):345-50.
2. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clinical Microbiology and Infection. 2006;12(9):826-36.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82.
4. Migliavacca R, Espinal P, Principe L, Drago M, Fugazza G, Roca I, et al. Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy. Diagn Microbiol Infect Dis. 2013;75(2):180-6.
5. Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA, et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. Journal of medical microbiology. 2015;64(7):767-73.
6. Ranjbar R, Farahani A. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrobial Resistance & Infection Control. 2019;8(1):172.
7. Gitahi N, Gathura P, Gicheru M, Wandia B, Nordin A. Multidrug-resistant Campylobacter jejuni, Campylobacter coli and Campylobacter lari isolated from asymptomatic school-going children in Kibera slum, Kenya [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research. 2020;9(92).
8. Moulana Z, Babazadeh A, Eslamdost Z, Shokri M, Ebrahimpour S. Phenotypic and genotypic detection of metallo-beta-lactamases in Carbapenem resistant Acinetobacter baumannii. Caspian J Intern Med. 2020;11(2):171-6.
9. Shoja S, Moosavian M, Rostami S, Farahani A, Peymani A, Ahmadi K, et al. Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries. Journal of the Chinese Medical Association. 2017;80(4):245-52.
10. Sadeghifard NK, Ranjbar R, Ghasemi A, Pakzad I, Zaeimi Yazdi J, Zaheri A, et al. A study of antimicrobial resistance of Acinetobacter baumanni and non-Acinetobacter baumanni strains isolated from three hospitals in Tehran Journal of Ilam Univarsity of medical science. 2006;14(3).
11. Ardebili A, Azimi L, Mohammadi-Barzelighi H, Owlia p, Beheshti M, Talebi M, et al. Determination of Resistance Pattern of Isolated Acinetobacter baumannii from Hospitalized Burned Patients in Motahari Hospital, Tehran. Journal of Advances in Medical and Biomedical Research. 2012;20(83):112-9.
12. Davoodi S, Boroumand M, Sepehriseresht S, Pourgholi L. Detection of VIM- and IMP-type Metallo-Beta-Lactamase Genes in Acinetobacter baumannii Isolates from Patients in Two Hospitals in Tehran. Iranian Journal of Biotechnology. 2015;13:63-7.
13. Dehghani M, Masjedian F, Mirnejad R, Imani Fooladi AA, Haghighat S. Antimicrobial Susceptibility Patterns and Distribution of bla(kpc) Genes among Acinetobacter baumannii Isolated from Patients at Tehran - Iran Hospitals. Journal of Pure and Applied Microbiology. 2012;6:707-12.
14. Erfani Y. Detection of bla NDM -1, bla VIM, and bla IMP genes in multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa from clinical isolates in Tehran hospitals. International Journal of Advanced Biotechnology and Research. 2017;8:500-6.
15. Akbari Dehbalaei M, Najar-Peerayeh S, Taherikalani M, Behmanesh M. Clinical Isolates of Acinetobacter baumannii From Tehran Hospitals: Pulsed-field Gel Electrophoresis Characterization, Clonal Lineages, Antibiotic Susceptibility, and Biofilm-forming Ability. Jundishapur J Microbiol. 2017;10(7):e13790.
16. Mirnejad R, Mostofi S, Masjedian F. Role of Class 2 Integron in Antibiotic Susceptibility Pattern of Acinetobacter baumannii Strains Isolated from Hospitals in Tehran. Avicenna Journal of Clinical Medicine. 2012;18(4):22-8.
17. Karmostaji A, Najar Peerayeh S, Hatef Salmanian A. Distribution of OXA-Type Class D β-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals. Jundishapur J Microbiol. 2013;6(5):e8219.
18. Pajand O, Rezaee MA, Nahaei MR, Mahdian R, Aghazadeh M, Soroush MH, et al. Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: Comparison of burn and non-burn strains. Burns. 2013;39(7):1414-9.
19. Azimi L, Talebi M, Pourshafie M, Owlia P. Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran. International journal of molecular and cellular medicine. 2015;4:46-53.
20. AlaviI MM, miri MM, Majid, Kouchek M, Goharani R, Sistanizad M, SafariI S, et al. Incident of imipenem-resistant Acinetobacter baumannii in general intensive care unit (ICU). 2014.
21. Saderi H, Owlia P. Pattern of resistance to different antibiotic groups among clinical isolates of Acinetobacter baumannii in two hospitals in Tehran. Daneshvar medicine. 2015;22(118).
22. Sharif M, Mirnejad R, Amirmozafari N. Molecular identification of TEM and SHV extended spectrum β-lactamase in clinical isolates of Acinetobacter baumannii from Tehran hospitals. J Gen Microb Immun. 2014;2:1-9.
23. Fallah F, Noori M, Hashemi A, Goudarzi H, Karimi A, Erfanimanesh S, et al. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica. 2014;2014:245162.
24. Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB. Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and blaOXA-23-like Genes Including a New Variant. Frontiers in Microbiology. 2015;6.
25. Haeili M, Ghodousi A, Nomanpour B, Omrani M, Feizabadi MM. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011. The Journal of Infection in Developing Countries. 2013;7(04):312-7.
26. Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii carrying bla oxA type genes isolated from hospitalized patients. Novelty in Biomedicine. 2013;1(2):54-61.
27. Goudarzi H, Azad M, Seyedjavadi SS, Azimi H, Salimi Chirani A, Fallah Omrani V, et al. Characterization of integrons and associated gene cassettes in Acinetobacter baumannii strains isolated from intensive care unit in Tehran, Iran. Journal of Acute Disease. 2016;5(5):386-92.
28. Maspi H, Mahmoodzadeh Hosseini H, Amin M, Imani Fooladi AA. High prevalence of extensively drug-resistant and metallo beta-lactamase-producing clinical Acinetobacter baumannii in Iran. Microbial Pathogenesis. 2016;98:155-9.
29. Ostad Asadolah-Malayeri H, Hakemi-Vala M, Davari K. Role of Aders and OXA23 Genes among Imipenem Resistant Acinetobacter baumannii Isolates from Two Hospitals of Tehran, Iran. Iranian Journal of Pathology. 2016;11(4):345-53.
30. Azad Khaledi DE, Saeid Amel Jamehdar, Seyed-Alireza Esmaeili, Alireza Neshani and Abbas Bahador. Expression of MFS efflux pumps among multidrug resistant Acinetobacter baumannii clinical isolates. Scholars Research Library. 2016.
31. Zanganeh Z, Eftekhar F. Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii. Jundishapur J Microbiol. 2015;8(9):e26545.
32. Azimi L, Lari A, Talebi M, Namvar AE, Jabbari M. Comparison between phenotypic and PCR for detection of OXA-23 type and metallo-beta-lactamases producer Acinetobacter spp. GMS Hygiene and Infection Control. 2013;8.
33. Khalilzadegan S, Sade M, Godarzi H, Eslami G, Hallajzade M, Fallah F, et al. Beta-Lactamase Encoded Genes blaTEM and blaCTX Among Acinetobacter baumannii Species Isolated From Medical Devices of Intensive Care Units in Tehran Hospitals. Jundishapur Journal of Microbiology. 2016;Inpress.
34. Azimi L, Rastegar Lari A, Alaghehbandan R, Alinejad F, Mohammadpoor M, Rahbar M. KPC-Producer Gram Negative Bacteria Among Burned Infants In Motahari Hospital, Tehran: First Report From Iran. Annals of burns and fire disasters. 2012;25.
35. Azimi L, Talebi M, Khodaei F, Najafi M, Rastegar Lari A. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of carbapenemases producing Acinetobacter baumannii isolated from burn patients. Burns. 2016;42.
36. Parviz Owlia LA, Abdolaziz Rastegar Lar. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Le Infezioni in Medicina.
37. Asadollahi P, Akbari M, Soroush S, Asadollahi K, Sayehmiri K, Makeki A, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns : journal of the International Society for Burn Injuries. 2012;38.
38. Zohreh Aminzadeh aTY. Drug-resistant post-neurosurgical nosocomial Acinetobacter baumannii meningitis in two Iranian hospitals. African Journal of Biotechnology. 2012;11(17).
39. Vafaei S, Mirnejad R, Amirmozafari N. Determining the Patterns of Antimicrobial Susceptibility and the Distribution of blaCTX-M Genes in Strains of Acinetobacter Baumannii Isolated from Clinical Samples. Journal of Isfahan Medical School. 2013;31(252).
40. M T-T, M L, SA J-M, M A, A RL, M FA, et al. Risk factors and antimicrobial susceptibility in ventilator associated pneumonia: a brief report. Tehran University Medical Journal. 2012;70(9):577-82.
41. Mirnejad R, Mostofi S, Masjedian F. Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. Asian Pacific Journal of Tropical Biomedicine. 2013;3(2):140-5.
42. Asadollahi K, Alizadeh E, Akbari M, Niakan M, Makeki A, Asadollahi P, et al. The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals. Roumanian archives of microbiology and immunology. 2010;70:153-8.
43. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and Genetic Characterization of Metallo-β-Lactamase and Carbapenamase Producing Strains of Acinetobacter Baumannii from Patients at Tehran Hospitals. Iranian journal of microbiology. 2011;3:68-74.
44. Mohammadi M. Distribution of Class D Carbapenemase and Extended-Spectrum b-Lactamase Genes among Acinetobacter Baumannii Isolated from Burn Wound and Ventilator Associated Pneumonia Infections. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 2017;11.
45. Mohammadi F, Goudarzi H, Hashemi A, Yosefi N, Khoshnood S, Sabzehali F. Detection of ISAba1 in Acinetobacter baumannii Strains Carrying OXA Genes Isolated From Iranian Burns Patients. Archives of Pediatric Infectious Diseases. 2016;inpress.
46. Babapour E, Haddadi A, Mirnejad R, Angaji S, Amirmozafari N. Study of drug resistance and ompA gene existence in clinical Acinetobacter baumannii isolates. Iranian journal of medical microbiology. 2017;11:30-8.
47. Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, Hashemi A. Phenotypic and Molecular Detection of Metallo-Beta-Lactamase Genes Among Imipenem Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Strains Isolated From Patients with Burn Injuries. Archives of Clinical Infectious Diseases. 2016;inpress.
48. Jazani N, et al. Antibacterial effects of Artemisia dracunculus essential oil on multi-drug resistant isolates of Acinetobacter baumannii. J Bacteriol. 2011;1:6.
49. Asadollahi K, Makeki A, Alizadeh E, Valadbaigi H, Soroush S, Maleki H, et al. Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta microbiologica et immunologica Hungarica. 2011;58:359-70.
50. Vahdani P, Yaghoubi T, Aminzadeh Z. Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran. International journal of preventive medicine. 2011;2:127-30.
51. Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Surveillance of Antimicrobial Susceptibility among Bacterial Isolates from Intensive Care Unit Patients of a Tertiary-Care University Hospital in Iran: 2006–2009. Chemotherapy. 2010;56(6):478-84.
52. Akbari M, Mahdi A, Niakan M, Mohammad N, Taherikalani M, Mehdi F, et al. Rapid identification of Iranian Acinetobacter Baumannii strains by single PCR assay using BLA oxa-51 -like carbapenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta microbiologica et immunologica Hungarica. 2010;57:87-94.
53. Moradi Tabriz H, Abd Elahi AR, Mehdipour B, Mahfouzi S. A.baumannii, infection rate and antimicrobial susceptibility in an Iranian tertiary care hospital Iranian Gournal of pathology(IJP). 2010;5(4):-.
54. Rahbar M, Mehrgan H, Aliakbari N. Prevalence of antibiotic-resistant Acinetobacter baumannii in a 1000-bed tertiary care hospital in Tehran, Iran. Indian journal of pathology & microbiology. 2010;53:290-3.
55. Rahbar M, Mehragan H, Haji Ali Akbari N. Prevalence of Drug Resistance in Nonfermenter Gram-Negative Bacilli. Iranian Journal of Pathology. 2010;5(2):90-6.
56. Mirsamadi ES, Goudarzi H, Ghalavand Z, Vala MH, Mirjalali H, Hashemi A, et al. Molecular Detection of Metallo-Beta-Lactamase genes in Clinical Isolates of Acinetobacter baumannii. Journal of Pure and Applied Microbiology. 2015;9:145-51.
57. Soroush S, Haghi-Ashtiani M, Emaneini M, Aligholi M, Sadeghifard N, Pakzad I, et al. Antimicrobial Resistance of Nosocomial Strain of Acinetobacter baumannii in Children’s Medical Center of Tehran: A 6-Year Prospective Study. Acta medica Iranica. 2009;48:178-84.
58. Aliramezani A, Douraghi M, Hajihasani A, Mohammadzadeh M, Rahbar M. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment. Microbial Pathogenesis. 2016;99:204-8.
59. Taherikalani M, Fatolahzadeh B, Bahram F, Emaneini M, Soroush S, Setareh S, et al. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran Hospitals. The new microbiologica. 2009;32:265-71.
60. Owrang M, Fallah F, Irani S, Rahbar M, Eslami G. Identification and Isolation of Insertion Sequences, ISAba1 and ISAba2, in Carbapenem Resistant Clinical Isolates of Acinetobacter baumannii from Hospitals in Tehran, Iran. Jundishapur Journal of Microbiology. 2017;In Press.
61. Peerayeh S, Karmostaji A. Molecular Identification of Resistance Determinants, Integrons and Genetic Relatedness of Extensively Drug Resistant Acinetobacter baumannii Isolated From Hospitals in Tehran, Iran. Jundishapur Journal of Microbiology. 2015;8.
62. Noori M, Karimi A, Fallah F, Hashemi A, Alimehr S, Goudarzi H, et al. High Prevalence of Metallo-beta-lactamase Producing Acinetobacter baumannii Isolated From Two Hospitals of Tehran, Iran. Archives of Pediatric Infectious Diseases. 2014;2.
63. Mandana Z, Mohamad Mehdi F, Sirous J, Alireza A, Azar S. High prevalence of OXA-type carbapenemases among Acinetobacter baumannii strains in a teaching hospital of Tehran. Acta Microbiologica et Immunologica Hungarica AMicr. 2017;64(4):385-94.
64. Navidinia M, Goudarzi M, Molaei Ramshe S, Farajollahi Z, Asl P, Zaka Khosravi S, et al. Molecular characterization of resistance genes in MDR-ESKAPE pathogens. Journal of Pure and Applied Microbiology. 2017;11:779-92.
65. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iranian journal of microbiology. 2011;3(2):68-74.
66. Mirshekar M, Shahcheraghi F, Azizi O, Badmasti F. Diversity of Class 1 Integrons, and Disruption of carO and dacD by Insertion Sequences Among Acinetobacter baumannii Isolates in Tehran, Iran. Microbial Drug Resistance. 2017;24.
67. Tavakol M, Momtaz H. Detection of the most prevalent antibiotic resistance genes in Acinetobacter baumannii strains isolated from hospitals infections and determination of their antibiotic resistance pattern. Biological journal of Microorganism. 2015;4(14).
68. Momtaz H, Khamesipour F, Tavakol M, Awosile B. Determination of Antimicrobial Resistance and Resistant Genes in Acinetobacter Baumannii from Human Clinical Samples. West Indian Medical Journal. 2015;66.
69. Boroumand M, Akhyani H, Sheikhvatan M, Yazdi S, Saboorian R, Hashemi S, et al. Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test. Iranian J Publ Health. 2012;38:130-3.
70. Aghamiri S, Amirmozafari N, Fallah J, Fouladtan B, Abdar M. Antibiotic Resistance Patterns and a Survey of Metallo-β-Lactamase Genes Including bla-IMP and bla-VIM Types in Acinetobacter baumannii Isolated from Hospital Patients in Tehran. Chemotherapy. 2016;61:275-80.
71. Beigverdi R, Sattari-Maraji A, Emaneini M, Jabalameli F. Status of carbapenem-resistant Acinetobacter baumannii harboring carbapenemase: First systematic review and meta-analysis from Iran. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2019;73:433-43.
72. Jazani NH, Zartoshti M, Babazadeh H, Ali-daiee N, Zarrin S, Hosseini S. Antibacterial Effects of Iranian Fennel Essential Oil on Isolates of Acinetobacter baumannii. Pakistan journal of biological sciences: PJBS. 2009;12:738-41.
73. Pournajaf A, Rajabnia R, Razavi S, Solgi S, Ardebili A, Yaghoubi S, et al. Molecular characterization of carbapenem-resistant Acinetobacter baumannii isolated from pediatric burns patients in an Iranian hospital. Tropical Journal of Pharmaceutical Research. 2018;17:135.
74. Feizabadi M, Fathollahzadeh B, Rasoolinejad M, Sadeghifard N, Aligholi M, Soroush S, et al. Antimicrobial susceptibility patterns and distribution of BlaAXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Japanese journal of infectious diseases. 2008;61:274-8.
75. Farshadzadeh Z, Hashemi F, Rahimi S, Pourakbari B, Esmaeili D, Haghighy Ma, et al. Wide Distribution of Carbapenem Resistant Acinetobacter baumannii in Burns Patients in Iran. Frontiers in Microbiology. 2015;6.
76. Gholami M, Hashemi A, Hakemi-Vala M, Goudarzi H, Hallajzadeh M. Efflux Pump Inhibitor Phenylalanine-Arginine Β-Naphthylamide Effect on the Minimum Inhibitory Concentration of Imipenem in Acinetobacter baumannii Strains Isolated From Hospitalized Patients in Shahid Motahari Burn Hospital, Tehran, Iran. Jundishapur journal of microbiology. 2015;8(10):e19048-e.
77. Rahbar M, Kabeh-Monnavar M, Vatan K, Fadaei-Haqi A, Shakerian F. Carbapenem resistance in gram-negative bacilli isolates in an Iranian 1000-bed tertiary hospital. Pak J Med Sci. 2007;24.
78. Mahdian S, Sadeghifard N, Pakzad I, Ghanbari F, Soroush S, Azimi L, et al. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran. Journal of Infection and Public Health. 2015;8(6):533-42.
79. Tafreshi N, Bababeekhou L, Ghane M. Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of bla OXA-24-like and bla OXA-58-like genes. Iranian Journal of Microbiology. 2020;11:502-9.
80. Savari M, Ekrami A, Shoja S, Bahador A. Plasmid borne Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) and AdeABC efflux pump conferring carbapenem-tigecycline resistance among Acinetobacter baumannii isolates harboring TnAbaRs. Microbial Pathogenesis. 2017;104.
81. Nasrolahei M, Zahedi B, Bahador A, Saghi H, Kholdi S, Jalalvand N, et al. Distribution of bla OXA-23, IS Aba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran. Annals of clinical microbiology and antimicrobials. 2014;13:38.
82. Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C. Molecular epidemiology of Acinetobacter baumannii in Iran: Endemic and epidemic spread of multiresistant isolates. The Journal of antimicrobial chemotherapy. 2014;69.
83. Rahmani M, Amirmozafari N, Oshagi M. An Investigation of the Presence of Oxacillinase genes (blaOXA-51 , bla OXA-23, blaOXA-58, bla OXA-24 ) in Acinetobacter baumannii Strains Isolated from Patients in Tehran Imam Khomeini Hospital and Shiraz Namazi Hospital, Iran. Qom Univ Med Sci J. 2015;9(10):55-63.
84. Peymani A, Higgins P, Nahaei M, Farajnia S, Seifert H. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, Northwest Iran. International journal of antimicrobial agents. 2012;39:526-8.
85. Peymani A, Nahaei M, Farajnia S, Hasani A, Mirsalehian A, Sohrabi N, et al. High prevalence of metallo-β-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Japanese journal of infectious diseases. 2011;64:69-71.
86. Sohrabi N, Farajnia S, Akhi M, Nahaei M, Naghili B, Peymani A, et al. Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran. Microbial drug resistance (Larchmont, NY). 2012;18:385-9.
87. Ranjbar R, Farahani A. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrobial Resistance & Infection Control. 2019;8.
88. Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. Journal of Global Antimicrobial Resistance. 2019;21.
89. Shirmohammadlou N, Zeighami H, Haghi F, Kashefieh M. Resistance pattern and distribution of carbapenemase and antiseptic resistance genes among multidrug-resistant Acinetobacter baumannii isolated from intensive care unit patients. Journal of Medical Microbiology. 2018;67.
90. Janbakhsh A, Khazaei S, Soroush A, Mirzaei S, Tarlan M, Tarlan S, et al. Antibiotic Resistance in Acintobacter Strains Isolated from Patients, Staff and Equipment of ICU Wards of the Hospital in Kermanshah, Iran. Journal of Kermanshah University of Medical Sciences. 2020;In Press.
91. Farsiani H, Mosavat A, Soleimanpour S, Nasab M, Salimizand H, Amel Jamehdar S, et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in northeast-Iran. Journal of medical microbiology. 2015;64.
92. Salimizand H, Menbari S, Ramazanzadeh R, Khonsha M, Vahedi M. DNA fingerprinting and antimicrobial susceptibility pattern of clinical and environmental Acinetobacter baumannii isolates: a multicentre study. Journal of Chemotherapy. 2016;28:277-83.
93. Sarhaddi N, Soleimanpour S, Farsiani H, Mosavat A, Dolatabadi S, Salimizand H, et al. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran. Journal of Global Antimicrobial Resistance. 2016;8.
94. Alaee N, Bahador A, Harzandi N. Molecular epidemiology and antimicrobial resistance of Acinetobacter baumannii isolated from Namazi hospital, in Shiraz by modified AFLP analysis. Journal of Microbial world. 2013;6(2 (15)).
95. Alaei N, Aziemzadeh M, Bahador A. Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran. Journal of Global Antimicrobial Resistance. 2016;5.
96. Japoni S, Farshad S, abdi-ali A, Japoni A. Antibacterial Susceptibility Patterns and Cross-Resistance of Acinetobacter, Isolated from Hospitalized Patients, Southern Iran. Iranian Red Crescent medical journal. 2011;13:832-6.
97. Pourabbas B, Firouzi R, Pouladfar G. Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex‎‏ isolates from nosocomial bloodstream infections in southern Iran. Journal of Medical Microbiology. 2016;65.
98. Moghadam M, Motamedifar M, Sarvari J, Sedigh H, Mousavi S, Moghadam F. Emergence of Multidrug Resistance and Metallo-beta-lactamase Producing Acinetobacter baumannii Isolated from Patients in Shiraz, Iran. Annals of Medical and Health Sciences Research. 2016;6:162.
99. Jafari S, Najafipour S, Kargar M, Abdollahi A, Mardaneh J, Fasihy Ramandy M, et al. Phenotypical Evaluation of Multi-Drug Resistant Acinetobacter Baumannii. Journal of Fasa University of Medical Sciences. 2013;2(4):254-8.
100. Kooti S, Motamedifar M, Sarvari J. Antibiotic resistance profile and distribution of Oxacilinase among clinical isolates of Acinetobacter baumannii in Shiraz teaching hospitals, 2012 - 2013. Jundishapur Journal of Microbiology(JJM). 2015;8(8).
101. Sarikhani Z, Nazari R, Nateghi Rostami M. First report of OXA-143-lactamase producing Acinetobacter baumannii in Qom, Iran. Iranian Journal of Basic Medical Sciences. 2017;20:1282-6.
102. Shoja S, Moosavian M, Peymani A, Tabatabaiefar ma, Rostami S, Ebrahimi N. Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran. Iranian Journal of Microbiology. 2013;5:315-22.
103. Shoja S, Moosavian M, Rostami S, Abbasi F, Tabatabaiefar ma, Peymani A. Characterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran. Jundishapur Journal of Microbiology. 2016;inpress.
104. Moosavian M, Sirous M, Shams N. Phenotypic and Genotypic Detection of Extended Spectrum B-lactamase and Carbapenemases Production Including bla TEM, bla PER and bla NDM-1 Genes Among Acinetobacter baumannii Clinical Isolates. Jundishapur Journal of Microbiology. 2017;In Press.
105. Mansour A, Navidifar T, Shooshtari F, Goodarzi H. Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii. Infection and Drug Resistance. 2019; 12:1171-80.
106. Salimizand H, Modarresi F, Azizi O, Mansouri S, Rahmati M, Barkhordari K. Antimicrobial Profile and Phenotypic Metallo-β-Lactamase Detection of Acinetobacter baumannii Isolated From Clinical and Environmental Specimens. Zahedan J Res Med Sci. 2015;17(6).
107. Saffari F, Monsen T, Karmostaji A, Azimabad F, Widerström M. Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran. Journal of Medical Microbiology. 2017;66.
108. Azizi O, shakibaie mr, Modaresi F, shahcherghi f. Molecular Detection of Class-D OXA Carbapenemase Genes in Biofilm and Non-Biofilm Forming Clinical Isolates of Acinetobacter baumannii. Jundishapur Journal of Microbiology. 2015;8:e21042.
109. Mohajeri P, Farahani A, Feizabadi M, Davoodabadi A, Noroozi B. The Prevalence of ESBL Isolates of Acinetobacter baumannii Using Pulsed- Field Gel Electrophoresis. Zahedan J Res Med Sci. 2013;15.
110. Mohajeri P, Farahani A, Sheini Mehrabzadeh R. Molecular Characterization of Multidrug Resistant Strains of Acinetobacter baumannii Isolated from Intensive Care Units in West of Iran. Journal of Clinical and Diagnostic Research. 2017;11:DC20-Dc2.
111. Mohajeri P, Farahani A, Mehdi F, Norozi B. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis. Indian journal of medical microbiology. 2015;33:87-91.
112. Norozi B, Farahani A, Mohajeri P, Davoodabadi A. Molecular epidemiology of hospital acquired OXA-carbapenemase-producing Acinetobacter baumannii in Western Iran. Asian Pacific Journal of Tropical Disease. 2014;4:S803-S7.
113. Karbasizade V. Antimicrobial resistance of acinetobacter baumannii isolated from intensive care units of Isfahan hospitals, Iran. Journal of Isfahan Medical School. 2012;30.
114. Rezaei A, Fazeli H, Moghadampour M, Halaji M, Faghri J. Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive. 2018;26:61-6.
115. Ghalebi M, Eslami G, Zandi H, Farhang A, Vakili M, Mohammadi N, et al. Survey of Antibiotic Resistance and Frequency of blaOXA-23 and blaOXA-24 Oxacillinase in Acinetobacter baumannii Isolated from Tracheal Tube Specimens of Patients Hospitalized in Intensive Care Units in Isfahan city. The Journal of Shahid Sadoughi University of Medical Sciences. 2017;25(1):1-10.
116. Ghajavand H, Havaei S, Nasr Esfahani B, Fazeli H, Moghim S. Frequency of multi-drug resistance acinetobacter baumannii isolates in intensive care units (ICU) of Isfahan Hospitals, Iran, via molecular method and their antimicrobial resistance patterns. Journal of Isfahan Medical School. 2014;32:1175-85.
117. J Vazirzadeh, H Ghajavand, L Heidari, P Behshood. Prevalence of Extended Spectrum Beta Lactamases (ESBLs) and Antibiotic Resistance Pattern Acinetobacter Baumannii Strains Isolated from Clinical Specimens in Isfahan City, Iran. Medical Laboratory Journal. 2015;9(3):32-9.
118. Shamsizadeh Z, Nikaeen M, Nasr Esfahani B, Mirhoseini SH, Hatamzadeh M, Hassanzadeh A. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environmental Health and Preventive Medicine. 2017;22.
119. Shokri D, Khorasgani M, Fatemi S, Soleimani Delfan A. Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients. Journal of medical microbiology. 2017;66.
120. Safari M, Saidijam M, Bahador A, Jafari R, Alikhani M. High Prevalence of Multidrug Resistance and Metallo-beta-lactamase (MβL) producing Acinetobacter Baumannii Isolated from Patients in ICU Wards, Hamadan, Iran. Journal of research in health sciences. 2013;13:162-7.
121. Bardbari A, Arabestani MR, Karami M, Keramat F, Alikhani M, Pooshang Bagheri K. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microbial Pathogenesis. 2017;108:122-8.
122. Safari M, Mozaffari Nejad AS, Bahador A, Jafari R, Alikhani M. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU). Saudi Journal of Biological Sciences. 2015;32.
123. Farahani Kheltabadi R, Moniri R, Shajari GR, Nazem Shirazi MH, Musavi SGA, Ghasemi A, et al. Antimicrobial Susceptibility patterns and the distribution of resistance genes among Acinetobacter species isolated from patients in shahid Beheshti hospital, Kashan. Feyz Journal of Kashan University of Medical Sciences. 2009;12(4):61-7.
124. Josheghani S, Moniri R, Firoozeh F, Sehat M, Dastehgoli K, Koosha H, et al. Emergence of blaOXA-Carrying Carbapenem Resistance in Multidrug-Resistant Acinetobacter baumannii in the Intensive Care Unit. Iranian Red Crescent Medical Journal. 2016;Inpress.
125. Madadi-Goli N, Moniri R, Bagheri-Josheghani S. Antibiotic resistance pattern and distribution of Vietnamese extended-spectrum- β lactamase (VEB-1) gene in Acinetobacter baumannii isolated from hospitalized patients in Kashan Shahid Beheshti hospital during 2013-2014. Feyz Journal of Kashan University of Medical Sciences. 2017;21(4):383-9.
126. Bagheri Josheghani S, Moniri R, Firoozeh F, Sehat M, Dasteh Goli Y. Susceptibility Pattern and Distribution of Oxacillinases and blaPER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in Iran. Journal of Pathogens. 2015;2015.
127. Japoni-Nejad A, Sofian M, van Belkum A, Ghaznavi-Rad E. Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran. Jundishapur Journal of Microbiology. 2013;6.
128. JaponiNejad AR, Sofian M, Ghaznavi-Rad E. Molecular detection of AdeABC efflux pump genes in clinical isolates of Acinetobacter baumannii and their contribution in imipenem resistance. Iranian South Medical Journal. 2014;17(5):815-23.
129. Bahadori azimabadi F, Karmostaji A. Evaluation of Oxacillinase Genes among Carbapenem Resistant Acinetobacter baumannii in Shahid Mohammadi Hospital of Bandar abbas, Iran in 2014-2015. Journal of Advances in Medical and Biomedical Research. 2015;23(101):45-54.
130. Moosavian M, Ahmadi K, Shoja S, Mardaneh J, Shahi F, Afzali M. Antimicrobial resistance patterns and their encoding genes among clinical isolates of Acinetobacter baumannii in Ahvaz, Southwest Iran. MethodsX. 2020;7.
131. Witchuda Kamolvit HES, and David L. Paterson. Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania. Microbial Drug Resistance. 2015;21(4):424-34.
132. Opazo-Capurro A, Domínguez M, Bello H, Amyes S, González-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. Journal of infection in developing countries. 2012;6:311-6.
133. Shams S, Hashemi A, Esmkhani M, Kermani S, Shams E, Piccirillo A. Imipenem resistance in clinical Escherichia coli from Qom, Iran. BMC Research Notes. 2018;11.
134. Schafer E, Malecki M, Téllez-Castillo C, Pfennigwerth N, Marlinghaus L, Higgins P, et al. Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany. Antimicrobial Resistance & Infection Control. 2019;8.
135. Low Y-M, Yap P, abdul jabar K, Ponnampalavanar S, Karunakaran R, Velayuthan R, et al. The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: Correlation between microbiological trends with host characteristics and clinical factors. Antimicrobial resistance and infection control. 2017;6:5.
136. Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Advanced Drug Delivery Reviews. 2014;78:3-13.
137. Nasiri MJ, Zamani S, Fardsanei F, Arshadi M, Bigverdi R, Hajikhani B, et al. Prevalence and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii: A Comprehensive Systematic Review of Cross-Sectional Studies from Iran. Microbial drug resistance (Larchmont, NY). 2020;26(3):270-83.
138. Nasrollah Sohrabi SF, Mohammad Taghi Akhi, Mohammad Reza Nahaei, Behrooz Naghili, Amir Peymani, Zohreh Amiri, Mohammad Ahangarzadeh Rezaee, and Nazli Saeedi. Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran. Microbial Drug Resistance. 2012;18(4):385-9.
139. Jabalameli F, Taki E, Emaneini M, Beigverdi R. Prevalence of metallo-²-lactamase-encoding genes among carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Iran. Revista da Sociedade Brasileira de Medicina Tropical. 2018;51:270-6.
140. Esfandiari A, Rashidian A, Masoumi Asl H, Rahimi Foroushani A, Salari H, Akbari Sari A. Prevention and control of health care-associated infections in Iran: A qualitative study to explore challenges and barriers. Am J Infect Control. 2016;44(10):1149-53.
141. Sarı A, Biçmen M, Gülay Z. The First Report on the Outbreak of OXA-24/40-Like Carbapenemase-Producing Acinetobacter baumannii in Turkey. Japanese journal of infectious diseases. 2013;66:439-42.
142. Azimi L, Talebi M, Pourshafie M-R, Owlia P, Rastegar Lari A. Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran. International Journal of Molecular and Cellular Medicine. 2015;4(1):46-53.